Aptamera Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $21.4M

Aptamera General Information

Description

Developer and provider of drugs intended for cancer. The company is actively pursuing DNA aptamers and small molecule drugs designed to attack cancer cells by interacting with novel molecular targets involved in cancer cell proliferation, enabling its clients to get treatment for cancer-related illnesses.

Contact Information

Website
www.aptamera.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 640 South Street
  • Suite 400
  • Louisville, KY 40202
  • United States
+1 (502)
Primary Industry
Drug Discovery
Acquirer
Antisoma
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 640 South Street
  • Suite 400
  • Louisville, KY 40202
  • United States
+1 (502)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aptamera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 04-Feb-2005 $21.4M Completed Clinical Trials - Phase 1
3. Early Stage VC 24-Dec-2001 Completed Startup
2. Seed Round Completed Startup
1. Grant $7M Completed Startup
To view Aptamera’s complete valuation and funding history, request access »

Aptamera Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anchorage Angels Angel Group Minority
Keyhorse Capital Venture Capital Minority
National Cancer Institute Government
National Institutes of Health Government
Prosperitas Investment Partners Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Aptamera FAQs

  • When was Aptamera founded?

    Aptamera was founded in 2001.

  • Where is Aptamera headquartered?

    Aptamera is headquartered in Louisville, KY.

  • What industry is Aptamera in?

    Aptamera’s primary industry is Drug Discovery.

  • Is Aptamera a private or public company?

    Aptamera is a Private company.

  • What is the current valuation of Aptamera?

    The current valuation of Aptamera is .

  • What is Aptamera’s current revenue?

    The current revenue for Aptamera is .

  • How much funding has Aptamera raised over time?

    Aptamera has raised $300K.

  • Who are Aptamera’s investors?

    Anchorage Angels, Keyhorse Capital, National Cancer Institute, National Institutes of Health, and Prosperitas Investment Partners are 5 of 6 investors who have invested in Aptamera.

  • When was Aptamera acquired?

    Aptamera was acquired on 04-Feb-2005.

  • Who acquired Aptamera?

    Aptamera was acquired by Antisoma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »